Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Root Cause Determination for Customer Complaint Biopharmaceutical Drug Product Samples with Abnormal Appearance
Yiwei Ma1, Jian Liu2, Alejandra Gallegos2
1Process Development, Amgen Inc, 1 Amgen Center Dr., Thousand Oaks, CA 91320, USA. snashed@amgen.com yma06@amgen.com.
Customer complaints about Amgen drug products were investigated. Root cause analysis revealed contamination originated from non-Amgen products at healthcare facilities, not manufacturing processes.
Area of Science:
- Pharmaceutical Science
- Quality Control
- Analytical Chemistry
Background:
- Customer complaints regarding drug product abnormalities can occur despite stringent quality control.
- Investigating these complaints is crucial for manufacturers to maintain product quality and safety.
Purpose of the Study:
- To investigate three distinct customer complaints involving Amgen drug products with visible abnormalities.
- To determine the root cause of product abnormalities and implement corrective actions.
Main Methods:
- Conducted comprehensive root cause analyses (RCAs) for each complaint.
- Utilized orthogonal analytical test methodologies to identify contaminants.
- Evaluated potential contamination sources, focusing on manufacturing versus healthcare provider facilities.
Main Results:
- RCAs excluded manufacturing processes as the source of contamination.
- Identified non-Amgen products (Vitamin B12, fosaprepitant, iron/saline) as contaminants in the affected vials.
- Concluded that mishandling at healthcare provider facilities was the likely cause.
Conclusions:
- Root cause determination is essential for effectively addressing customer complaints.
- Identifying external contamination sources ensures biopharmaceutical product quality, safety, and efficacy.
- Effective complaint handling involves communication with relevant parties.
More Related Videos
07:00Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
Published on: August 11, 2017
07:29HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis
Published on: November 11, 2022
Related Concept Videos
Clinically Relevant Drug Product Specifications: Methods of Establishment
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Dissolution: Requirements and Profile Comparison
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence